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ABSTRACT
SUBANESTHETIC KETAMINE FOR POSTOPERATIVE ANALGESIA:
AN EVIDENCED-BASED PROJECT
by Jeremy Alan Vance
December 2017
Roughly 100 million surgical procedures are performed in the United States
(U.S.) each year and more than 80% of these patients experience acute postoperative
pain. Pain costs the U.S. an estimated $560 to $635 billion annually and is a significant
contributor to national rates of mortality, morbidity, and disability. Despite these
findings, patients continue to receive suboptimal postoperative pain relief.
The adjunct administration of subanesthetic ketamine is opioid-sparing and can
improve the effectiveness of a multimodal pain management approach. This project used
an exploratory descriptive design to examine how an evidence-based presentation
impacted the clinical practice of certified registered nurse anesthetists (CRNAs). A
questionnaire describing individual pain management practices before and after an
evidence-based presentation on multimodal pain management using subanesthetic
ketamine was included. Participants completed a pre-intervention questionnaire. The
student registered nurse anesthetist (SRNA) then presented an evidence-based teaching
intervention on subanesthetic ketamine based on a synthesis of current research.
Consistent with current literature, a subanesthetic ketamine dose of 0.5 mg/kg was
suggested to participants. As recommended in the literature, subanesthetic ketamine
could be administered during the preoperative or intraoperative periods with effective
control of pain on emergence. Two weeks later, a post-intervention questionnaire was
ii

mailed to the SRNA using provided self-addressed envelopes. All four participants
reported the evidence-based intervention influenced their consideration of subanesthetic
ketamine administration. Increases in subanesthetic administration frequencies were also
noted.
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CHAPTER I – INTRODUCTION
Postoperative pain is a significant concern for surgical patients in the United
States (U.S.) (Ladha, Patorno, Huybrechts, Liu, Rathmell, & Bateman, 2016). Most
patients undergoing a surgical procedure experience acute postoperative pain and less
than half of these patients report adequate postoperative pain relief (Chou et al., 2016).
Perioperative pain management is a crucial component of anesthetic care and can affect
the amount of pain patients feel postoperatively. Optimal management of this pain poses
unique challenges to anesthesia providers, as it requires an understanding of the
pathophysiology of pain, the techniques available to decrease pain, procedure specificity,
and the situational awareness to assess and direct care as needed. Inadequate treatment of
this pain has major consequences to the patient, including needless suffering, delayed
recovery, and extended hospital stays following surgery. It also increases the risk for
developing chronic pain, leads to higher rates of complications, higher morbidity, and
mortality rates, and places a financial burden on health care recipients in the U.S. (Khana
et al., 2011).
Problem Statement
Roughly 100 million surgical procedures are performed in the U.S. each year
(Centers for Disease Control and Prevention [CDC], 2010). Approximately 86% of
patients undergoing a surgical procedure in the U.S. experience acute postoperative pain
and 75% of these patients report the severity as moderate, severe, or extreme
(Apfelbaum, Chen, Mehta, & Gan, 2003; Chou et al., 2016). Pain costs the U.S. an
estimated $560 to $635 billion dollars annually and is a significant contributor to national
rates of mortality, morbidity, and disability (Institute of Medicine [IOM], 2011).
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Approximately $261 to $300 billion per year are spent on medical care associated with
pain (Gaskin & Richard, 2011). This estimate does not include indirect costs of pain,
e.g., missed working days and lost wages. The Institute of Medicine (IOM) provides
three estimates of indirect costs in the U.S. per year: missed working days at about $11.6
to $12.7 billion, missed hours of work at about $95.2 to $96.5 billion, and lower wages at
about $190.6 to $226.3 billion (IOM, 2011). Inadequate treatment of postoperative pain
results in higher utilization of resources and increased hospitalization and pharmaceutical
costs (Strassels, Connie, & Daniel, 2002).
Poorly managed postoperative pain is associated with adverse clinical outcomes
(Gan, Habib, Miller, White, & Apfelbaum, 2014). Some of these outcomes include
thromboembolisms, coronary ischemia, pulmonary complications, longer hospital stays,
higher readmission rates, needless suffering, increased risk of post-surgical
complications, and development of chronic pain (American Society of Anesthesiologists
[ASA], 2012; Apfelbaum et al., 2003). Unrelieved postoperative pain is also associated
with increased morbidity and mortality rates, and increased hospital costs (Apfelbaum et
al., 2003). Gan, Habib, Miller, White, and Apfelbaum (2014) examined the preoperative
psychological stresses associated with surgery and found that post-surgical pain was the
primary concern of 80% of patients. Of these patients, roughly 53% reported high levels
of anxiety (Gan et al., 2014). Anxiety is associated with increased heart rate and blood
pressure, arrhythmias, shortness of breath, and sleep problems. Anxiety can make pain
worse; it enhances the pain experience and decreases a patient’s coping ability (Institute
for Quality and Efficiency in Health Care, 2014).
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Background and Significance
In 1996, The American Pain Society (APS) reported that pain should be addressed
with the same regard as other vital signs. They emphasized the importance of routine and
continual assessments with necessary interventions to treat pain (American Pain Society
[APS], 2008). In 2000, The Joint Commission introduced an initiative stressing that
patients have the right to appropriate assessment and management of pain, further
emphasizing the importance of pain as the fifth vital sign. Over the last two decades,
concerted efforts by federal and private agencies have focused on improving pain
treatment and setting pain management standards (APS, 2008). Collectively, these
organizations emphasized the need for change in the treatment and prevention of pain.
Critical developments in pain treatment standards further evolved in 2000 with
the U.S. Congress’ proclamation of the “Decade of Pain Control and Research”
(Brennan, 2015, p. 212). During this time, a dissemination of science, technology,
research, and evidence-based practice (EBP) began changing pain management practices
(Brennan, 2015). In 2001, the Joint Commission declared pain management is the
responsibility of health care providers and consequently established provider standards
for assessing and managing pain. The Centers for Medicare and Medicaid (CMS)
partnered with the Agency for Healthcare Research and Quality (AHRQ) in the early
2000s to develop the Hospital Consumer Assessment of Healthcare Providers and
Systems (HCAHPS) (CMS, 2016). Implemented in 2006, this survey was the first
publicly reported, nationally standardized survey that measured and compared patients’
perceptions of the care they received while in the hospital. For institutions receiving
inpatient prospective payment systems (IPPS), a pay-for-performance culture was created
3

and pain management methods now had direct implications on hospital reimbursements,
creating an economic motivation to improve pain management practices (CMS, 2016).
Despite these efforts for the last two decades, patients continued to report moderate to
severe pain after surgery (Apfelbaum et al., 2003; Gan et al., 2014).
The growing emphasis of adequate pain control and postoperative pain relief
introduced the concept of multimodal analgesia in the 1990s (Kehlet & Dahl, 1993).
Multimodal analgesia is the combination of two or more drug classes, or nonpharmacologic interventions, used to achieve an additive or synergistic reduction in pain
through complementary mechanisms of action along multiple sites of the nociceptive
pathway (Helander et al., 2017). Traditionally, the mainstay of postoperative pain relief
has been opioids (Ladha et al., 2016). However, large doses of opioids have undesirable
side effects such as respiratory depression, sedation, hypotension, nausea, vomiting, and
constipation (Ladha et al., 2016). Large doses can also result in acute tolerance,
hyperalgesia, and central sensitization (ASA, 2012). In 2012, the APS collaborated with
the American Society of Anesthesiologists (ASA) and the American Society of Regional
Anesthesia and Pain Medicine (ASRA) to release a guideline for perioperative pain
management, strongly recommending the adoption of advanced multimodal analgesia
protocols for all surgical patients (Chou et al., 2016). There are numerous treatment
adjuncts available to implement a multimodal approach including gabapentinoids,
acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), regional anesthesia,
and ketamine. Combing two or more drug classes with different mechanisms of action,
multimodal analgesia targets specific areas in multiple pain pathways, thus inhibiting
patients’ sensations and/or perceptions of pain (ASA, 2012; IOM, 2011).
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Postoperative pain is a serious problem and concern for both anesthesia providers
and patients. Despite its inception nearly 40 years ago, ketamine’s resurgence as an
analgesic is attributed to the low- or subanesthetic dose ranges (Ramachandran & Rewari,
2016; Yang & Moitra, 2013). The use of ketamine has been shown to decrease
perioperative opioid requirements and reduce postoperative pain intensity (Hurley,
Murphy, & WU, 2015). Notwithstanding this evidence, some anesthesia providers are
hesitant to use this drug as a treatment for pain due to various side effects such as
hallucinations, tachycardia, lacrimation, delirium, psychomimetic effects, or an increase
in intracranial pressure (Yang & Moitra, 2013). Recent reports note that ketamine
administered in lower doses may not produce such side effects; and, subanesthetic
ketamine was associated with reduced perioperative pain scores, decreased perioperative
opioid requirements, and reduced postoperative nausea and vomiting (Yang & Moitra,
2013).
Research suggests that inadequate analgesia throughout the perioperative period is
associated with poor health outcomes and significantly contributes to healthcare costs in
the U.S. Despite these findings, patients continue to report moderate to severe pain levels
postoperatively for the last decade (Apfelbaum et al., 2003; Gan et al., 2014). Therefore,
the challenge to anesthesia providers is delivering a patient specific plan of care tailored
to meet the emotional, behavioral, and pharmacological needs of the individual.
Needs Assessment
Despite advancements in pharmacology and surgical techniques, more than 80%
of patients who undergo surgical procedures experience acute postoperative pain (Gan et
al., 2014). Early in a clinical rotation, I observed many postoperative patients needing
5

hydromorphone immediately upon arriving to post-anesthesia care unit (PACU). When I
asked providers whether they considered administering subanesthetic ketamine as an
analgesic adjunct, many of them admitted they had not. Over time, I assessed that
patients who received intraoperative subanesthetic ketamine had smoother wake-ups and
did not require an immediate dosing of analgesic upon arrival to PACU. I considered this
as opportunity to change CRNAs’ practice to include subanesthetic ketamine to reduce
the opioid requirements of patients throughout the perioperative period.
Clinical Question
Implementing EBP optimizes patient outcomes, lowers healthcare costs, and
improves quality of care (Melnyk, Fineout-Overholt, Gallagher-Ford, & Kaplan, 2012).
To identify the best evidence on subanesthetic ketamine, the EBP process began with the
formulation of a clinical question. The clinical question for this project was: are CRNAs
willing to change their current practice to include subanesthetic ketamine as an adjunct in
the multimodal management of acute postoperative pain?
Purpose Statement
The purpose of this project was to evaluate whether CRNAs were willing to
change their practice to include subanesthetic ketamine as an adjunct in the multimodal
management of acute postoperative pain. Evidence suggests that a multimodal approach
that includes subanesthetic ketamine reduces total opioid consumption during the
postoperative period and is an effective adjunct for postoperative analgesia (Helander et
al., 2017).
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Theoretical Framework
Model for Evidenced-based Change in Practice
The EBP movement represented a major paradigm shift in healthcare that is
driven by research utilization and clinical expertise to inform clinical decision making
and guide clinical practice (Stevens, 2013). Evaluating, integrating, and implementing
EBP in the clinical setting improves patient outcomes, reduces healthcare costs, and
enhances clinical judgment (Melnyk, Fineout-Overholt, Gallagher-Ford, & Kaplan,
2012). Numerous theoretical frameworks, i.e., conceptual models, were developed to
organize the processes of making an evidence-based change in practice.
The EBP model by Rosswurm and Larrabee (1999) provided the theoretical
framework that guided this Doctor of Nursing Practice (DNP) project. This model was
designed to systematically guide practice change projects through the process of
integrating evidence-based changes in practice (Melnyk & Fineout-Overholt, 2011). The
model is a progression through six steps from needs assessment through sustaining a
practice change. This project used steps one through five. Step six, sustaining a practice
change, is discussed in the recommendation section of this paper.
Step one included identification of a problem and assessment of the need for a
change in practice that improves acute pain in the postoperative period. The needs
assessment was based on clinical observation regarding the use of ketamine in a
multimodal pain management plan and a systematic review of the literature. Also,
stakeholders were identified as CRNAs, the student registered nurse anesthetists (SRNA),
and head of anesthesia at the chosen facility.
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Step two involved identifying sources of evidence, planning a search, and
conducting the search for the best evidence on the perioperative use of subanesthetic
ketamine for acute postoperative pain. Systematic reviews on subanesthetic ketamine,
clinical practice guidelines by the APS and the ASA, and single randomized controlled
trials, were all considered in step two.
Step three was a critical appraisal and synthesis of the evidence on subanesthetic
ketamine as an analgesic adjunct for acute postoperative pain. There was sufficient
quality evidence supporting the efficacy of subanesthetic ketamine for perioperative pain
management. A facility in the Southeastern U.S. was considered, as well as, the costs,
time obligations, and overall feasibility of completing this DNP project in its entirety was
considered.
Step four involved defining and designing the proposed practice change that
included an evidenced based administration plan for subanesthetic ketamine. This plan
and administration regimen was presented to the facility’s CRNAs. Step five involved
implementing and evaluating this project. During this time, close communication with
the participating CRNAs was imperative. Obtaining verbal feedback from the CRNAs
regarding implementation of the project and evaluating a need for adjustments to the
implementation plan of this project was an import aspect in this step. Evaluating the
processes as well as the outcomes and costs associated with this project are important for
making final recommendations for adoption of the practice.
DNP Essentials
This project utilized the competencies as outlined in The Essentials of Doctoral
Education for Advanced Nursing Practice. Fulfillment of the core essentials of the DNP
8

degree as defined by the American Association of Colleges of Nursing (AACN) are
necessary to confer the DNP degree (Chism, 2013). This project employed a systemsbased approach to conceptualize and improve practice quality within the culture and
structure of the host facility (see Appendix A) (Zaccagnini & White, 2014).
Review of Literature
A literature search was conducted in July of 2017 using Ovid (MEDLINE),
Pubmed, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and
Scopus to identify, appraise, and synthesize current evidence on the use of ketamine in
acute perioperative pain management (see Figure 1). Studies meeting inclusion and
exclusion criteria were identified by title and abstract. Inclusion criteria included:
systematic reviews, randomized controlled trials (RCTs), and studies published in
English between 2002 and 2017. Exclusion criteria included: animal or laboratory studies
and non-English studies. The following search terms were used in various orders and
combinations: ketamine, postoperative, pain, analgesia, multimodal, low-dose, and
subanesthetic. The initial literature search identified 312 studies. Of these, 259 studies
were duplicates and excluded. A total of 53 articles resulted from this search. An
additional 36 articles were excluded according to defined criteria and 17 articles
remained. After full text screening data extraction, five studies were appropriate for use
in this DNP project (see Appendix B).
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Figure 1. Review of Literature PRISMA Flow Diagram.
Note: Flow diagram for article selection. Adapted from Moher, D., Liberati A., Tetzlaff J., & Altman, D. (2009). “The PRISMA
Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.” PLoS Med 6(7):
e1000097. doi:10.1371/journal.pmed1000097

Ketamine has unique anesthetic properties that make it adaptable to various
clinical situations. It is often described as unique because no other single drug has the
combined hypnotic, analgesic, and amnesic effects that ketamine distinctly shows (Gao,
Rejaei, & Liu, 2016). Ketamine is traditionally used as a general anesthetic, especially in
high risk patients with shock or cardiovascular instability, hypovolemia, trauma, severe
anemia, and bronchospasm (Nagelhout & Plaus, 2013). It is also used in obstetrics for
induction of high risk patients such as those with fetal distress and acute hemorrhage, and
10

ketamine is used to supplement regional techniques during delivery and the postpartum
period (Nagelhout & Plaus, 2013). Renewed clinical interest in ketamine has recently led
to its use in the treatment of depression, suicidal ideations, complex regional pain
syndromes, cancer pain, alcohol addiction, heroin addiction, asthma exacerbations,
wheezing, and pain during Propofol injection, (Gao, Rejaei, & Liu, 2016).
Ketamine is a phencyclidine derivative that predominately effects N-methyl-Daspartate (NMDA) receptors via noncompetitive antagonism (Yang & Moitra, 2013). It
is primarily supplied as a racemic mixture of the R(-) and S(+) isomer forms (Patel, Patel,
& Roth, 2011). The S(+) isomer has 4 times the affinity to bind with NMDA receptors,
two times the analgesic potency, and fewer psychomimetic effects with its
administration, than the R(-) isomer. Ketamine is water and lipid soluble and rapidly
crosses the blood brain barrier. Hepatic cytochrome P450 enzymes CYP3A4 and
CYP2B6 metabolize ketamine into norketamine that is excreted in urine and bile (Patel,
Patel, & Roth, 2011).
Ketamine has the unique characteristic of creating dissociation between the
thalamocortical and limbic systems; in fact, the term referred to as dissociative anesthesia
was coined specifically for ketamine (Nagelhout & Plaus, 2013). Unlike other general
anesthetics, the pharmacokinetic and pharmacodynamic properties of ketamine make it
an ideal drug for the unstable and high risk patient. It increases cerebral metabolic rate
(CMRO2), intracranial pressure (ICP), and cerebral blood volume (CBV). The
cardiovascular effects of ketamine occur via sympathetic mediated stimulation and
inhibition of catecholamine reuptake, producing an increased blood pressure, heart rate,
and cardiac output. Ketamine is a potent bronchodilator and enhances thoracic
11

compliance. Patients maintain airway reflexes, functional residual capacity, minute
ventilation, and tidal volume. Ketamine causes nystagmus, increased intraocular pressure
(IOP), increased oral and respiratory secretions, and increased muscle tone (Kurdi,
Theerth, & Deva, 2014; Nagelhout & Plaus, 2013).
Ketamine administration should be carefully considered in patients who are
comorbid with increased ICP, hypertension (HTN), congestive heart failure (CHF),
psychiatric disorders, increased IOP, or angina (Kurdi, Theerth, & Deva, 2014).
However, the pharmacological effects of ketamine are dose dependent. At lower
subanesthetic doses, ketamine is primarily an analgesic. In the subanesthetic dose range,
there is no respiratory depression and rarely are there psychological and major
sympathomimetic effects that are observed at general anesthetic dose ranges (Kurdi,
Theerth, & Deva, 2014; Nagelhout & Plaus, 2013).
Ketamine’s analgesic properties are attributable to NMDA receptor antagonism
(White, 2013). Blocking nociceptive and inflammatory mediators of pain at the NMDA
receptor decreases a patient’s pain perception. Evidence supports the analgesic properties
of ketamine; however, many studies cite the heterogeneity of studies and differences in
dose ranges for low dose ketamine (White, 2013).
Numerous studies investigate ketamine administration as an analgesic adjunct
during the perioperative period. A systematic review by Laskowski, Stirling, McKay,
and Lim (2011) focused on randomized clinical trials (RCTs) and identified 70 studies
involving 4,701 patients that used ketamine for perioperative pain control (Laskowski,
Stirling, McKay, & Lim, 2011). The study limited ketamine administration without the
use of regional anesthesia and found that ketamine administration had an opioid sparing
12

effect. This means that there was a decrease in total opioid consumption and a prolonged
time to first analgesic administration postoperatively, that was significant for thoracic,
abdominal, and orthopedic procedures (Laskowski et al., 2011).
Jouguelet-Lacoste, La Colla, Schilling, and Chelly (2015) examined the use of
infusion or single, subanesthetic ketamine bolus for postoperative pain control. A
systematic review of clinical trials and meta-analyses between 1966 and 2013 identified 5
meta-analyses and 39 clinical trials that met inclusion criteria. Of the 39 clinical trials on
subanesthetic ketamine administration, 26 were conducted using a single bolus followed
by continuous infusion, 11 using only single boluses, and 2 using continuous infusions.
Out of the 2,482 patients in the 39 clinical trials, 1,403 received ketamine. The
distribution of studies according to surgery type were: 7 spine surgeries; 1 cardiac
surgery; 22 bowel surgeries; 6 arthroplasties; 1 each of ear, nose, and throat surgeries;
and 2 studies that combined surgeries (Jouguelet-Lacoste et al., 2015).
All five meta-analyses identified by Jouguelet-Lacoste, et al. concluded that
subanesthetic ketamine used as an analgesic adjunct decreased pain scores of and opioid
consumption by surgical patients (Jouguelet-Lacoste et al., 2015). Three of these studies
reported a mean reduction of morphine consumption of 32% to 50% and a reduction of
postoperative rescue analgesics of 30% to 50%. Four out of 5 meta-analyses found that
pain scores 24 hours postoperatively were significantly reduced in 87.5% of patients who
received intravenous (iv) ketamine (Jouguelet-Lacoste et al., 2015). To assess
subanesthetic ketamine, study heterogeneity was noted; however, these studies were
included in this project based on their primary outcomes, i.e, postoperative opioid
consumption and/or 24-hour postoperative pain scores (Jouguelet-Lacoste et al., 2015).
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Six studies, representing 456 patients, 252 of whom received ketamine, assessed
the use of subanesthetic ketamine as an intraoperative bolus (Jouguelet-Lacoste et al.,
2015). Four out of 6 studies reported an opioid sparing effect and 2 of the 6 studies
reported significant reduction in postoperative pain scores. Subanesthetic ketamine
administration reduced opioid consumption by an average of 39.25% at 24 hours
postoperatively. This study defined subanesthetic ketamine as less than 1.2-mg/kg as an
infusion and no more than 1-mg/kg when administered as a bolus. The findings indicate
that a subanesthetic ketamine infusion at a rate of <1.2-mg/kg/h during the intraoperative
period decreased opioid consumption by 40% and lowered pain scores. There were no
reported complications of subanesthetic ketamine at 48 hours after surgery; however,
optimal dose or treatment regimen was not ascertained (Jouguelet-Lacoste et al., 2015).
Kaur, Saroa, and Aggarwal in 2015 identified 80 patients undergoing an open
cholecystectomy and found subanesthetic ketamine was an effective analgesic up to 6
hours postoperatively (Kaur, Saroa, & Aggarwal, 2015). These patients received a preincisional 0.2-mg/kg bolus of ketamine followed by a 0.1-mg/kg/h infusion that ran
intraoperatively to the end of the procedure. Pain scores and opioid consumption were
significantly reduced in the first 6 hours postoperatively. None of the patients
experienced ketamine associated side effects such as hallucinations, prolonged sedation,
or marked dissociation on emergence (Kaur, Saroa, & Aggarwal, 2015).
Ketamine has a wide margin of safety at subanesthetic and general anesthetic dose
ranges; and, 4 out of 5 of the meta-analyses identified by Jouguelet-Lacoste et al.,
concluded subanesthetic ketamine was safe when administered as an analgesic adjunct
and did not increase the incidence of adverse effects (Jouguelet-Lacoste et al., 2015).
14

Subanesthetic ketamine use had no impact on sedation scores and was found to decrease
the incidence of postoperative nausea and vomiting. The one study that did report
negative effects did not deem the effects a safety issue, rather the effects noted in the
study were psychomimetic in nature, short term, and stopped with the administration of a
benzodiazepine (Jouguelet-Lacoste et al., 2015).
Five studies assessed the administration of a single subanesthetic ketamine bolus
or repeated boluses intraoperatively (Jouguelet-Lacoste et al., 2015). Subanesthetic
ketamine was not associated with any serious side effects or any increase in serious side
effects. Eleven of the studies reported no difference in subanesthetic ketamine versus
placebo administration with regards to side effects, i.e., postoperative nausea and
vomiting, sedation, and psychomimetic effects. No indications of liver toxicity were
observed in any of the 39 clinical trials included in this review (Jouguelet-Lacoste et al.,
2015).
A systematic review by Bell, Dahl, Moore and Kalso (2006) identified 37
randomized controlled clinical trials and 53 other studies with treatment regimens
exploring the use of intravenous ketamine for perioperative pain control. A total of 2,137
patients were studied, of which 1,210 received ketamine. Postoperative opioid
consumption was reduced 24 hours postoperatively with pre-incisional ketamine
administration in 76% of the treatment groups (Bell, Dahl, Moore and Kalso, 2006). This
study reviewed the optimal analgesic doses of ketamine and divided its findings into 4
groups: 1 group with an estimated dose of 10-mg, 1 group with an estimated dose of 30mg, 1 group with an estimated dose of approximately 65-mg, and a final group with an
estimated dose of approximately 250-270-mg. The evidence revealed that there was no
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significant difference in morphine-sparing effects when the ketamine dose was increased
above a dose of approximately 30mg (Bell et al., 2006).
The adverse effects of ketamine reported by Bell et al. (2006) were found to be
equal in the placebo treated groups. Twenty-one of the 37 trials found no psychomimetic
effects such as hallucinations, bad dreams, or dysphoria, in the groups receiving
intravenous ketamine for perioperative pain. Psychomimetic effects were reported in
four trials and in one placebo group; however, the study determined these occurrences did
not impair patient safety. Four of the trials reported increased sedation scores,
specifically during the first fifteen minutes postoperatively after extubation. Diplopia
was reported as an adverse effect in three of the trials (Bell et al., 2006).
Summary
Postoperative pain is undertreated in most surgical patients in the U.S. and has
been so for over a decade (Chou et al., 2016). Unrelieved postoperative pain puts
patients at risks, and, these risks have immediate and potentially chronic consequences.
This project was guided by Rosswurm and Larrabee (1999) EBP model. A clinical need
was identified and a comprehensive literature review appraisal identified the best
evidence supporting the use of subanesthetic ketamine in a multimodal pain management
regimen. Evidence supports the analgesic properties of subanesthetic ketamine
administration and its efficacy in treating acute perioperative pain. When added as an
adjunct to multimodal pain management regimens, subanesthetic ketamine reduced
postoperative pain scores and opioid requirements postoperatively.
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CHAPTER II – METHODOLOGY
Effective postoperative pain management improves clinical and economic
outcomes (Apfelbaum et al., 2003; Gan et al., 2014). Despite evidence on the benefits of
a multimodal perioperative analgesic regimen, a multimodal approach is often underused
in clinical practice (Benhamou et al., 2008). This project used an exploratory descriptive
design to examine how an evidence-based presentation impacted the clinical practice of
CRNAs.
Ethical Considerations
A letter of support from the host facility and an approval from the Institutional
Review Board (IRB) at The University of Southern Mississippi (USM) was obtained
(Protocol number 17091103) (see Appendix C and D). The questionnaires contained the
following statements: “[p]articipation in this project is voluntary and not required.
Completion of this survey implies your consent to participate. You may choose to
withdraw from this project at any time” (see Appendix E and F). No personally
identifiable data was collected.
Participants
A convenience sample of CRNAs practicing at a facility located in the
Southeastern U.S. was recruited. Recruitment involved the SRNA approaching each of
the CRNAs and briefly discussing the project, its purpose and goals, and time
requirements. Four out of the 5 (80%) CRNAs approached agreed to participate. The
fifth CRNA indicated that she was not a full-time employee and declined to participate in
the project.
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Design
This project included a questionnaire describing individual pain management
practices before and after an evidence-based presentation on multimodal pain
management using subanesthetic ketamine. At the start of the project, participants were
provided with a packet containing a pre-intervention questionnaire with an envelope and
a post-intervention questionnaire with self-addressed stamped envelope. Each packet had
identically numbered pre- and post-intervention questionnaires that were unique to that
packet. Using this numbering system preserved anonymity and provided a means of
evaluating changes in individual participants.
The SRNA presented an evidence-based teaching intervention on subanesthetic
ketamine, based on a synthesis of current research. This presentation provided key points
on: multimodal pain management, the pharmacokinetics and pharmacodynamics of
subanesthetic ketamine, the role of subanesthetic ketamine in a multimodal pain
management regimen, and the clinical applications of subanesthetic ketamine. Consistent
with current literature, a subanesthetic ketamine dose of 0.5-mg/kg was suggested to
participants. As recommended in the literature, subanesthetic ketamine could be
administered during the preoperative or intraoperative periods with effective control of
pain on emergence.
At the end of the presentation, the participants’ email addresses were collected for
a post-intervention reminder message that was sent one week. The email, which was not
associated with the uniquely numbered pre- and post-intervention questionnaires,
reminded participants to complete and mail the post-intervention questionnaire. Two
weeks after the education intervention, each CRNA completed the post-intervention
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questionnaire and mailed it to the SRNA in the self-addressed stamped envelope
provided.
Data Collection
The data collection instrument for this DNP project consisted of two seven-item
Likert type questionnaires (see Appendix E and F). The pre-intervention questionnaire
assessed each CRNA’s pre-intervention approach to managing perioperative pain, their
use of analgesic adjuncts, and their use of subanesthetic ketamine in multimodal
analgesia. Participants completed the pre-intervention questionnaire, sealed it in the
provided blank envelope, and handed the envelope to the SRNA. The post-intervention
questionnaire was designed to assess changes in ketamine use by participating CRNAs.
Each questionnaire took less than 5 minutes to complete. The SRNA developed the
questionnaire. Face validity was achieved through the presentation of the questionnaire
to subject matter experts.
Data collected during this project was secured in a locked file cabinet that only
the SRNA could access. Electronic data was secured on the SRNA’s password protected
laptop to which only the SRNA had access. Six months after the completion of degree
requirements have been verified, written data will be shredded. Electronic data will be
permanently deleted.
Data Analysis
Data collected for this project measured individual practice patterns pre- and postintervention. Demographic data limited to gender, age, and number of years in practice,
was collected. Frequency counts were used to describe the participants. Upon
completion of the project, results were drafted in a final paper for the DNP project.
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Findings were disseminated to the group of participating CRNAs as well as other
interested persons at the host organization at which time the project was openly
discussed.
Summary
An exploratory descriptive design was used to examine how an evidencedpresentation impacted the clinical practice of CRNAs. CRNAs were recruited and data
was collected using pre- and post-intervention questionnaires. The evidenced-based
presentation was based on a synthesis of current research and served as the intervention
for this project. After collection of the post-intervention questionnaires, data was
analyzed and the results computed.
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CHAPTER III – RESULTS
A total of four CRNAs completed the pre- and post-intervention questionnaires
and engaged in the evidence-based teaching intervention. Two of the 4 were female
(50%) and 2 of the 4 were male (50%) (see Figure 2). The four CRNAs amassed 62
years of anesthesia experience between them, ranging 6 to 31 years of anesthesia
experience (see Figure 3).

GENDER
Male

Female

Figure 2. Demographic Data.
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CRNA 2

CRNA 3

CRNA 4

Figure 3. Years of Anesthesia Experience

When asked if a unimodal or multimodal pain management approach described
their typical practice, 3 out of 4 (75%) use a multimodal approach and 1 out of 4 (25%)
use a unimodal approach (see Figure 4). When asked to rank analgesic adjuncts from
most to least likely to use, 3 out of 4 (75%) of respondents ranked cyclooxygenase-2
(COX-2) selective nonsteroidal anti-inflammatory drugs (NSAIDs) as their number one
or top analgesic adjunct choice. Three out of 4 (75%) of respondents ranked ketamine as
their second go to analgesic adjunct. Calcium channel α-2-δ antagonists, acetaminophen,
and nonselective NSAIDs, had the third, fourth, and fifth ranking (see Figure 5).
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UNIMODAL VS. MULTIMODAL PAIN MANAGEMENT
REGIMENS
Unimodal

Multimodal

Figure 4. Unimodal vs Multimodal Pain Management Regimens.

PRE- AND POST-INTERVENTION ADJUNCT RANKINGS
4

CRNA

3

2

1

0
COXIBs

Nonselective
NSAIDs

Calcium channel
α-2-δ antagonists

Ketamine

Acetaminophen

Analgesic Adjunct Type
Ranked #1

Ranked #2

Ranked #3

Ranked #4

Ranked #5

Figure 5. Pre- and Post-Intervention Adjunct Rankings. Adjunct rankings remained
unchanged pre- and post-intervention.
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When asked how many times participants administered subanesthetic ketamine in
the previous two weeks, 2 out of 4 (50%) of participants administered subanesthetic
ketamine approximately 1 to 2 times, 1 out of 4 (25%) participants administered
subanesthetic ketamine 3 to 5 times, and 1 out of 4 (25%) did not administer
subanesthetic ketamine. Four out of 4 (100%) of the participants completed the pre- and
post-intervention questionnaires. Of the participants, 4 out of 4 (100%) stated that the
evidenced-based intervention influenced their decision to consider the administration of
subanesthetic ketamine as an adjunct for perioperative pain control. In the postintervention questionnaire, four participants stated he or she used subanesthetic ketamine
for pain. Most participants increased their use of subanesthetic ketamine over the twoweek period (see Figure 6).

Ketamine Administrations Frequencies Pre- and
Post-Intervention
3

CRNA

2

1

0
None

1-2 times

3-5 times

Subanesthetic Ketamine Administrations
Pre-Intervention

Post-Intervention

Figure 6. The Number of Post-Intervention Ketamine Administrations.
Note: Number of times subanesthetic ketamine was administered over a two-week period, post-intervention.
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Summary
This project examined CRNA practice regimens for managing postoperative pain.
The adjunct use of subanesthetic ketamine in a multimodal pain management plan preand post-intervention was obtained and described in this section. Discussion of the
results including implications and limitations are discussed in the following chapter.
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CHAPTER IV - Discussion
Implications for Clinical Practice
Well-managed postoperative pain is important to anesthesia providers because it
improves patient outcomes (Gan et al., 2014). Integrating an opioid-reduced multimodal
pain management plan that includes subanesthetic ketamine has implications on several
fronts (see Appendix F). Opioid related mortalities continue to rise in the U.S. and
surgical patients receiving opioids are more likely to become opioid dependent and longterm users (Brummett et al., 2017; Rudd, 2016). Multimodal pain management plans that
effectively treat postoperative pain reduces patient opioid consumption, improves patient
satisfaction, enhances patient recovery, reduces hospital stay, and decreases the
likelihood of acute pain transitioning to chronic pain (Gan et al., 2014). Second,
improving the management of pain reduces healthcare cost in the U.S (Meissner et al.,
2015). An efficient opioid-reduced anesthetic that incorporates multimodal pain
management strategies is also cost-effective and would reduce pain related healthcare
costs (Meissner et al., 2015). Lastly, opioid-related side effects and adverse events would
decrease through opioid-reduced multimodal management of postoperative pain
(Helander et al., 2017).
Limitations
There were several limitations in this project. First, this project used a selfselected group that collected self-reported data, thus introducing bias into the results.
Second, although a subanesthetic dose of 0.5-mg/kg was suggested, it is not known for
certain that this dosage was used. Third, the total number of patients eligible to receive
subanesthetic ketamine during the two-week period is unknown. As a result, it is
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impossible to know what percent of eligible patients received the intervention. Fourth,
data on the effect of subanesthetic ketamine on patient pain postoperatively was not
assessed because the project was not able to follow patients through their first 24-hours
postoperatively to determine the impact on eventual opioid use. Finally, 2 weeks may be
too short to assess sustainability of a practice change. The long-term benefit of nonopioid anesthesia for patients could not be assessed within the timeframe of this project.
Thus, the efficiency and effectiveness of subanesthetic ketamine as part of a multimodal
pain management regimen could not be established.
Other circumstances limited the findings of this project. A small sample size
produced non-generalizable results with no reliability, minimal internal validity, and no
external validity. This project also had an insufficient time frame. Patients with
contraindications to ketamine administration may have limited the number of times
participants could safely utilize the medication in such a short time period which could
have effected results.
Recommendations for Future Study
Based on evidence cited in this project, the use of subanesthetic ketamine for
postoperative analgesia can be anticipated to improve patient outcomes when part of a
multimodal pain management plan. Future studies should examine barriers to
subanesthetic ketamine administration. For example, some CRNAs cite the cost of a
multi-dose vial and the necessity of wasting doses as barriers for adoption. Therefore, it
would be important to understand what the impact of prefilled syringes would be on the
decision to include ketamine in a multimodal pain management plan. A study looking at
ketamine usage before and after pharmacy provides single dose syringes would provide
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data for this potential barrier. Future studies should examine the opioid-sparing effects of
subanesthetic ketamine by measuring the amounts opioids patients receive
postoperatively using morphine equivalents. What procedure and patient specific
attributes increase postoperative opioid consumption despite subanesthetic ketamine
administration?
Future studies should monitor patient outcomes over time. The sixth and final
step of the EBP model by Rosswurm and Larrabee involves integrating and maintaining a
change in practice that includes subanesthetic ketamine as an adjunct in the multimodal
management of acute postoperative pain (Rosswurm & Larrabee, 1999). To sustain a
change in practice patient outcomes must be periodically monitored
Conclusion
This project described pain management practices before and after an evidencebased presentation on multimodal pain management using subanesthetic ketamine.
Unmentioned until now, and relevant to this project, is the opioid crisis. Opioid addiction
and abuse is a public health problem that is now an epidemic of opioid overdoses and
opioid related deaths (Rudd, 2016). The problem is so widespread that many surgical
patients are concerned with taking opioids preoperatively and post-discharge
(Apfelbaum, Chen, Mehta, and Gan, 2003). If given a choice, roughly 72% of surgical
patients prefer a non-narcotic analgesic after surgery (Apfelbaum, Chen, Mehta, and Gan,
2003). Their reasoning was because non-narcotic medication are less addictive (49%)
and have fewer side effects (18%) (Apfelbaum, Chen, Mehta, and Gan, 2003). Over
500,000 Americans have died from drug overdose from 2000 to 2015 and 91 people die
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the same fate every day (Rudd, 2016). Exploring opioid sparing multimodal approaches
that utilize subanesthetic ketamine has national implications to public health.
Postoperative pain management is a challenging and pivotal component of
anesthesia. Despite their efficacy and place in anesthesia, opioids as mainstay analgesics
have failed to provide patients with optimal postoperative pain control for more than a
decade. Unimodal opioid use increases postoperative risk for opioid related adverse
events and can increase patient risk for becoming opioid dependent and long-term users
(Brummett et al., 2017).
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APPENDIX A – DNP Essentials
Table A1.
The AACN Essentials of Doctoral Education for Advanced Nursing Practice
Essential
I.

How the Essential was Achieved

Scientific Underpinnings

This project described the pathophysiological

for Practice

effects of acute pain, explained the
pharmacology of multimodal analgesia, and
discussed the pharmacokinetics and
pharmacodynamics of ketamine.
Considering this information, strategies to
translate research to practice were developed.

II.

Organizational and

This project evaluated pain management

Systems Leadership for

regimens of CRNAs in a facility in the

Quality Improvement and

Southeastern U.S. Strategies for effective

Systems Thinking

perioperative pain management using
subanesthetic ketamine as an adjunct in the
multimodal management of acute
postoperative pain were presented to improve
quality of care.

III.

Clinical Scholarship and

This project appraised and disseminated the

Analytical Methods for

most current evidence on subanesthetic

Evidence-Based Practice

ketamine administration for acute
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postoperative pain. This evidence was
presented to CRNAs and a evidence-based
change in practice that included subanesthetic
ketamine was proposed.
V.

Health Care Policy for

This project advocated for surgical patients

Advocacy in Health Care

by proposing an evidenced-based change in
practice to improve the quality of pain
management in this population and influence
institutional leadership to support
implementation of this evidenced-based
practice change. This project proposed an
evidence-based practice change utilizing
subanesthetic ketamine to improve the
treatment of pain through the postoperative
period.

VII.

Clinical Prevention and

To avert the opioid crisis in the U.S., this

Population Health for

project asserted that effective pain

Improving the Nation’s

management during the postoperative period

Health

decreases the risk for acute pain transitioning
to chronic pain and the prolonged need
and/or dependency on opioid.
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VIII.

Advanced Nursing

Practice

This project proposed a practice change that
includes the use of subanesthetic ketamine as
an adjunct in the multimodal management of
acute postoperative pain.

Note: Chism, L. (2013). The doctor of nursing practice: A guidebook for role
development and professional issues (2nd ed.). Burlington, MA: Jones & Bartlett
Learning.
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APPENDIX B – Review of Literature
Table A2. Literature Matrix
Author, Year, Level/
Title
Grade

Purpose

Design

Sample/
Data
Collection

Outcome,
Recommendations

Gao, M.,
Rejaei, D., &
Liu, H.
(2016).
Ketamine use
in current
clinical
practice.

I

Pharmacokinetics Meta- Systematic Analgesic/Low dose
and
analysis review of range 0.25-1 mg/kg;
pharmacodynamics
literature evidence supports the
of ketamine;
use of ketamine for
clinical application
acute pain
of ketamine
management in
including risks and
postoperative period.
benefits
Preoperative dose of
0.1mg/kg showed
opioid sparing effect.
For postoperative
pain, low-dose
reduced opioid
requirements in first
24 hours
postoperatively and
reduced postoperative
nausea and vomiting.

JougueletLacoste, J., La
Colla, L.,
Schilling, D.,
& Chelly, J. E.
(2015). The
Use of
Intravenous
Infusion or
Single Dose of
Low-Dose
Ketamine for
Postoperative
Analgesia: A
Review of the
Current
Literature.

I

Evaluate the
Systema Review of
efficacy of low-tic
literature
dose ketamine in Review including
managing
all
postoperative pain
randomized
controlled
trials,
metaanalysis,
and
systematic
reviews

Kaur, S.,
Saroa, R., &

II

Evaluate the effect Double 80 patients Treatment group
of low-dose bolus blind
undergoing received preoperative
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39 clinical trials
assessed infusion and
bolus of low dose
ketamine. Low dose
defined as < 1.2
mg/kg. Mean
reduction in opioid
use in 40% of
patients. Low-dose
ketamine also result
in lower pain scores
and no major
complications were
found up to 48 hours
postoperatively.

Aggarwal, S.
(2015). Effect
of
intraoperative
infusion of
low-dose
ketamine on
management
of
postoperative
analgesia.
Laskowski,
K., Stirling,
A., McKay,
W. P., & Lim,
H. J. (2011). A
systematic
review of
intravenous
ketamine for
postoperative
analgesia.

followed by
intraoperative
infusion on
postoperative pain.

I

random- open
ized
cholecystec
controll -tomy
-ed trial

bolus of 0.2 mg/kg
and pre-incision
infusion of 0.1
mg/kg/h up to the end
of surgery where it
was discontinued.
Effective analgesia
for first six hours
postoperatively.

Evaluate the
System- Review of
efficacy of
atic
literature
ketamine as
Review from 1966
adjunct in
to 2010
multimodal pain
that
management plan.
included all
randomized
controlled
trials,
doubleblind, and
placebocontrolled,
that
utilized
ketamine to
decrease
postoperati
-ve pain

Ketamine effective
adjunct in reducing
postoperative pain.
47 studies identified,
reduction in total
opioid consumption
and an increase in
time to first analgesic
were observed in all
studies (P<0.001).
Greatest efficacy by
surgical site
identified as:
thoracic, upper
abdominal, major
orthopedic
procedures. When
ketamine efficacious
for pain, patients
experienced less
postoperative nausea
and vomiting.
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APPENDIX E – Pre-Intervention Questionnaire

Data Collection Instrument: Pre-Intervention Questionnaire

This questionnaire is intended to assess your current practice and typical approach to managing
pain during the perioperative period. Please complete each of the following questions. When you are
finished, place the questionnaire in the provided self-addressed envelope and mail to the principal
investigator.
Participation in this project is voluntary and not required. Completion of this survey implies your
consent to participate. You may choose to withdraw from this project at any time.
Thank you for your participation in this project.

1. Gender:
a. Male
b. Female
2. Age: _______years
3. Years practice anesthesia: _______years
4. Do you typically use a unimodal or multimodal pain management regimen?
a.
b.
c.
d.

Unimodal
Multimodal
Don’t know
Comments:
__________________________________________________________________

5. If you do use a multimodal regimen, rank the following adjuncts by how frequently you administer
the drugs for their analgesic properties (rank from most frequent #1 to least frequent #)
a. ____ Cyclooxygenase-2(COX-2) selective nonsteroidal anti-inflammatory drugs
(NSAIDs)(COXIBs)
b. ____ Nonselective NSAIDs
c. ____ Calcium channel α-2-δ antagonists (gabapentin, pregabalin)
d. ____ Ketamine
e. ____ Acetaminophen
6. Over the last two weeks, how many times have you administered subanesthetic ketamine for pain?
a. 1-2 times
b. 3-5 times
c. None, I did not administer subanesthetic ketamine
d. Don’t know

7. Based on the evidence provided during this evidenced-based project, are you more likely to
consider subanesthetic ketamine as an adjunct for perioperative pain control?
a. Yes
b. No
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APPENDIX F – Post-Intervention Questionnaire

Data Collection Instrument: Post-Intervention Questionnaire

This questionnaire is intended to assess your current practice and typical approach to
managing pain during the perioperative period. Please complete each of the following questions.
When you are finished, place the questionnaire in the provided self-addressed envelope and mail
to the principal investigator.
Participation in this project is voluntary and not required. Completion of this survey
implies your consent to participate. You may choose to withdraw from this project at any time.
Thank you for your participation in this project.

1. Gender:
a. Male
b. Female
2. Age: _______years
3. Years practice anesthesia: _______years
4. Do you typically use a unimodal or multimodal pain management regimen?
a.
b.
c.
d.

Unimodal
Multimodal
Don’t know
Comments:
__________________________________________________________________

5. If you do use a multimodal regimen, rank the following adjuncts by how frequently you
administer the drugs for their analgesic properties (rank from most frequent #1 to least
frequent #)
a. ____ Cyclooxygenase-2(COX-2) selective nonsteroidal anti-inflammatory drugs
(NSAIDs)(COXIBs)
b. ____ Nonselective NSAIDs
c. ____ Calcium channel α-2-δ antagonists (gabapentin, pregabalin)
d. ____ Ketamine
e. ____ Acetaminophen
6. Over the last two weeks, how many times have you administered subanesthetic ketamine
for pain?
a. 1-2 times
b. 3-5 times
c. None, I did not administer subanesthetic ketamine
d. Don’t know
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APPENDIX G – Logic Model
Table A3. Logic Model
Resources
• CRNA
• Researcher
• Time

Activities
• Conduct a
comprehensive and
systematic
review of the
literature
• Present
findings to
CRNA
• Discuss
current pain
management
plan with
CRNA

Outputs

Short & Long
Term Outcomes

• Summary
of major
findings
to
propose
practice
change

• Short term
(1-3 years)
improved
management
of
postoperative pain

• Conduct
an
evidenced
-based
practice
change
proposal

• Long term
( 4-6 years)
facility
guideline on
the use of
multimodal
pain
management
strategies
that includes
subanesthetic ketamine
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Impact
• Multimodal a
standard of
care
• Reduction
in facility
costs
• Improved
patient
outcomes
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